This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignees: University of Ghent, Vib Vzw. Active years: 2024.
Company Filing History:


Years Active: 2024
Title: The Innovations of Wim Nerinckx in Immunoglobulin Glycosylation
Introduction
Wim Nerinckx, a notable inventor based in Astene, Belgium, has made significant contributions to the field of biotechnology through his innovative work on glycosylation of immunoglobulin domains. With one patent to his name, Nerinckx has focused on enhancing the functionality of immunoglobulin proteins by modifying their glycosylation properties.
Latest Patents
Nerinckx's patent, titled "Glycosylation of variable immunoglobulin domains," presents a groundbreaking approach to producing immunoglobulin variable domain proteins. This invention includes nucleotide sequences that code for polypeptides with engineered glycosylation acceptor sites. By providing methods for generating glycosylated variants of immunoglobulin domains, Nerinckx has opened new avenues for therapeutic applications in immunology.
Career Highlights
Throughout his career, Nerinckx has worked with esteemed organizations such as VIB (Vlaamse Instituut voor Biotechnologie) and Universiteit Gent. His role in these institutions has been pivotal in advancing research and innovation in the field of glycosylation and its implications in protein biology.
Collaborations
Collaboration has been a key aspect of Nerinckx's work. He has partnered with noteworthy peers, including Nico Callewaert and Bram Laukens, enhancing the research outcomes and impact of his inventions in the scientific community. This spirit of collaboration emphasizes the importance of teamwork in addressing complex biotechnological challenges.
Conclusion
Wim Nerinckx's contributions to the glycosylation of immunoglobulin domains illustrate the significant potential of targeted innovations in biotechnology. As the research in this field continues to evolve, Nerinckx's work serves as an inspiring example of how inventors can drive progress through creativity and collaboration. His patent not only showcases innovative techniques but also lays the groundwork for future advancements in therapeutic protein development.